CA Stock MarketDetailed Quotes

ASP Acerus Pharmaceuticals Corp

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayTrading Sep 4 09:30 ET
0Market Cap0.00P/E (TTM)

Acerus Pharmaceuticals Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2021/FY
Stock NameRevenueRatio
Termination fees-6.25M151.32%
Product revenue2.12M-51.32%
Product

No Data

Industry

No Data

Region Currency:USD
2021/FY
Stock NameRevenueRatio
U.S.-4.48M108.49%
Canada64K-1.55%
Rest of world287K-6.94%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg